Clinical trial
A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and…
NCT00477295 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00477295 |
|---|---|
| Title | A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy |
| Official title | A Randomized, Multi-centre, Double-blind Study, to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Zonisamide, Carbamazepine |
| Enrollment | 583 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Jan 1, 2011 |
| First posted | May 23, 2007 |
| Last update posted | Dec 24, 2015 |
| Countries | Australia, Denmark, France, Germany, Greece, Hungary, India, Italy, Poland, Russia, Serbia, Slovakia and 6 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: